Avidity Partners Management LP Rocket Pharmaceuticals, Inc. Transaction History
Avidity Partners Management LP
- $885 Million
- Q4 2024
A detailed history of Avidity Partners Management LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Avidity Partners Management LP holds 1,053,300 shares of RCKT stock, worth $9.7 Million. This represents 1.5% of its overall portfolio holdings.
Number of Shares
1,053,300
Previous 749,000
40.63%
Holding current value
$9.7 Million
Previous $13.8 Million
4.3%
% of portfolio
1.5%
Previous 0.85%
Shares
13 transactions
Others Institutions Holding RCKT
# of Institutions
244Shares Held
108MCall Options Held
262KPut Options Held
159K-
Rtw Investments, LP New York, NY17.7MShares$163 Million3.63% of portfolio
-
Wellington Management Group LLP Boston, MA14MShares$129 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.58MShares$60.6 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$57 Million0.0% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx5.2MShares$47.9 Million1.26% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $697M
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...